Fundraising Fox

Nob Hill Therapeutics

Albuquerque, US · Founded 2016 · Delaware corporation · 8 employees on LinkedIn · 2 known investors

Founders & leadership

NG
Noel GreenbergerExecutive
YL
Yun LiNamed on SEC filing

Board

CJChris Japp
Chris JappinBoard MemberManaging Partner at Tramway Venture Partners
PA
Paul AtkinsBoard director
RC
Robert Calvin GoforthBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$2.4M disclosed across 6 rounds · 2016–2024

$1.8MraisedAug 2024 · 17 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris JappDirector
  • Noel GreenbergerExecutive Officer, Director
  • Paul AtkinsDirector
  • Robert Calvin GoforthDirector
Offering amount
$3.9M
Amount sold
$1.8M
Minimum investment
$10K
Proceeds to insiders
$55.4K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
$150KraisedSep 2021 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Yun LiExecutive Officer, Director
  • Paul AtkinsDirector
  • Robert Calvin GoforthDirector
Offering amount
$600K
Amount sold
$150K
Minimum investment
$50K
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$50KraisedApr 2021 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Calvin GoforthDirector
  • Yun LiExecutive Officer, Director
Offering amount
$200K
Amount sold
$50K
Minimum investment
$50K
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$75KraisedNov 2019 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Yun LiExecutive Officer, Director
  • Robert Calvin GoforthDirector
Offering amount
$500K
Amount sold
$75K
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$143.5KraisedNov 2018 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • R. Calvin GoforthDirector
  • Yun LiExecutive Officer, Director
Offering amount
$400K
Amount sold
$143.5K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedApr 2018 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jee ShinExecutive Officer, Director
  • R. Calvin GoforthDirector
  • Mark KiddExecutive Officer
Offering amount
$250K
Amount sold
$250K
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Nob Hill Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

Who are Nob Hill Therapeutics's investors?
Nob Hill Therapeutics's investors include Houston Angel Network, Tramway Venture Partners.
How much funding has Nob Hill Therapeutics raised?
Nob Hill Therapeutics has disclosed $2.4M raised across 6 rounds.
Where is Nob Hill Therapeutics headquartered?
Nob Hill Therapeutics is headquartered in Albuquerque, US.